A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
CONTEXT: Non-islet cell tumor hypoglycemia (NICTH) results from the hypersecretion of pro-IGF-II by a large, usually mesenchymal tumor. Detection of pro-IGF-II in serum is a potential tumor marker in these patients. OBJECTIVE: The aim of this study was to validate a rapid and reliable method for de...
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
2005
|
| _version_ | 1826305932052660224 |
|---|---|
| author | Miraki-Moud, F Grossman, AB Besser, M Monson, J Camacho-Hübner, C |
| author_facet | Miraki-Moud, F Grossman, AB Besser, M Monson, J Camacho-Hübner, C |
| author_sort | Miraki-Moud, F |
| collection | OXFORD |
| description | CONTEXT: Non-islet cell tumor hypoglycemia (NICTH) results from the hypersecretion of pro-IGF-II by a large, usually mesenchymal tumor. Detection of pro-IGF-II in serum is a potential tumor marker in these patients. OBJECTIVE: The aim of this study was to validate a rapid and reliable method for determining serum pro-IGF-II. PATIENTS: Serum samples from 16 patients with NICTH were studied. MAIN OUTCOME MEASURE: The main outcome measure was serum concentration of pro-IGF-II determined by immunoblot analysis of pro-IGF-II and mature IGF-II after 16.5% tricine-SDS-PAGE, which was compared with pro-IGF-II measured by standard RIA after size-exclusion acid chromatography. RESULTS: The analyses of patients' sera by size-exclusion acid chromatography showed that 68 +/- 19% of IGF-II were present in the pro-IGF-II form, whereas only 18 +/- 4% corresponded to pro-IGF-II in controls. Scanning densitometry of immunoblots showed 67 +/- 16% in the bands corresponding to pro-IGF-II in patients' sera, compared with 27 +/- 9% in controls. The detection sensitivity of tricine-SDS-PAGE method was the same as for size-exclusion chromatography, but the tricine-SDS-PAGE method is quicker and requires smaller amounts of serum. CONCLUSION: Tricine-SDS-PAGE followed by IGF-II immunoblot analysis provides a rapid, reproducible, and sensitive method for the separation of serum pro-IGF-II from mature IGF-II and is a useful laboratory evaluation of patients with a clinical diagnosis of NICTH. |
| first_indexed | 2024-03-07T06:40:18Z |
| format | Journal article |
| id | oxford-uuid:f90dd682-4445-48db-b1db-6f3bd5edf153 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:40:18Z |
| publishDate | 2005 |
| record_format | dspace |
| spelling | oxford-uuid:f90dd682-4445-48db-b1db-6f3bd5edf1532022-03-27T12:55:00ZA rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f90dd682-4445-48db-b1db-6f3bd5edf153EnglishSymplectic Elements at Oxford2005Miraki-Moud, FGrossman, ABBesser, MMonson, JCamacho-Hübner, C CONTEXT: Non-islet cell tumor hypoglycemia (NICTH) results from the hypersecretion of pro-IGF-II by a large, usually mesenchymal tumor. Detection of pro-IGF-II in serum is a potential tumor marker in these patients. OBJECTIVE: The aim of this study was to validate a rapid and reliable method for determining serum pro-IGF-II. PATIENTS: Serum samples from 16 patients with NICTH were studied. MAIN OUTCOME MEASURE: The main outcome measure was serum concentration of pro-IGF-II determined by immunoblot analysis of pro-IGF-II and mature IGF-II after 16.5% tricine-SDS-PAGE, which was compared with pro-IGF-II measured by standard RIA after size-exclusion acid chromatography. RESULTS: The analyses of patients' sera by size-exclusion acid chromatography showed that 68 +/- 19% of IGF-II were present in the pro-IGF-II form, whereas only 18 +/- 4% corresponded to pro-IGF-II in controls. Scanning densitometry of immunoblots showed 67 +/- 16% in the bands corresponding to pro-IGF-II in patients' sera, compared with 27 +/- 9% in controls. The detection sensitivity of tricine-SDS-PAGE method was the same as for size-exclusion chromatography, but the tricine-SDS-PAGE method is quicker and requires smaller amounts of serum. CONCLUSION: Tricine-SDS-PAGE followed by IGF-II immunoblot analysis provides a rapid, reproducible, and sensitive method for the separation of serum pro-IGF-II from mature IGF-II and is a useful laboratory evaluation of patients with a clinical diagnosis of NICTH. |
| spellingShingle | Miraki-Moud, F Grossman, AB Besser, M Monson, J Camacho-Hübner, C A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia. |
| title | A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia. |
| title_full | A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia. |
| title_fullStr | A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia. |
| title_full_unstemmed | A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia. |
| title_short | A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia. |
| title_sort | rapid method for analyzing serum pro insulin like growth factor ii in patients with non islet cell tumor hypoglycemia |
| work_keys_str_mv | AT mirakimoudf arapidmethodforanalyzingserumproinsulinlikegrowthfactoriiinpatientswithnonisletcelltumorhypoglycemia AT grossmanab arapidmethodforanalyzingserumproinsulinlikegrowthfactoriiinpatientswithnonisletcelltumorhypoglycemia AT besserm arapidmethodforanalyzingserumproinsulinlikegrowthfactoriiinpatientswithnonisletcelltumorhypoglycemia AT monsonj arapidmethodforanalyzingserumproinsulinlikegrowthfactoriiinpatientswithnonisletcelltumorhypoglycemia AT camachohubnerc arapidmethodforanalyzingserumproinsulinlikegrowthfactoriiinpatientswithnonisletcelltumorhypoglycemia AT mirakimoudf rapidmethodforanalyzingserumproinsulinlikegrowthfactoriiinpatientswithnonisletcelltumorhypoglycemia AT grossmanab rapidmethodforanalyzingserumproinsulinlikegrowthfactoriiinpatientswithnonisletcelltumorhypoglycemia AT besserm rapidmethodforanalyzingserumproinsulinlikegrowthfactoriiinpatientswithnonisletcelltumorhypoglycemia AT monsonj rapidmethodforanalyzingserumproinsulinlikegrowthfactoriiinpatientswithnonisletcelltumorhypoglycemia AT camachohubnerc rapidmethodforanalyzingserumproinsulinlikegrowthfactoriiinpatientswithnonisletcelltumorhypoglycemia |